Antimalarial activity of inhibitors of ADP-ribosyl transferase against Plasmodium yoelii infection in mice. 1. Preliminary data.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001549:Benzamides / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009536:Niacinamide / Q000031:analogs & derivatives / Q000494:pharmacology; D009713:Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D010961:Plasmodium / Q000187:drug effects; D011065:Poly(ADP-ribose) Polymerases; D013805:Theobromine / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D000962:Antimalarials; D001549:Benzamides; D009536:Niacinamide; C024785:5-methylnicotinamide; D002738:Chloroquine; C025160:3-aminobenzamide; D013806:Theophylline; D011065:Poly(ADP-ribose) Polymerases; D009713:Nucleotidyltransferases; C025159:3-methoxybenzamide; D013805:Theobromine